Friday 21st April 2023 |
Text too small? |
Rua Bioscience (NZX: RUA ) today announced the resignation of Chief Financial Officer, Hamish White, effective 30 June 2023. The company is incredibly grateful for the contributions he has made during his tenure and wishes him well in his future endeavours.
"The Board would like to express our appreciation to Hamish for his dedication and passion. Hamish has been with Rua since the beginning and was one of Rua’s first employees. As CFO, he successfully helped the company navigate the NZX listing and has been a key contributor in establishing Rua as a leading company in the medical cannabis industry," said Rua Bioscience Chairman, Trevor Burt.
Rua Bioscience CEO, Paul Naske, says “Hamish has been part of New Zealand’s medical cannabis industry from its inception. He has played a critical role in steering the company through the New Zealand regulations and maximising the global commercial opportunities presented by this growth industry. We wish Hamish all the best for the next stage of his career. We thank him and his family for their massive contribution to Rua’s kaupapa.”
The company will put a transition plan in place and will seek a suitable replacement to continue Rua’s future development.
Ends.
This announcement is authorised by:
Paul Naske
Chief Executive Officer, Rua Bioscience
For more information, please contact info@ruabio.com
No comments yet
October 3rd Morning Report
BRW - Bremworth Enters Into Scheme Implementation Agreement
October 2nd Morning Report
Devon Funds Morning Note - 2 October 2025
Meridian welcomes Government reforms
October 1st Morning Report
Heartland publishes Annual Report, Climate Report and NOM
SCL - Scales increases ownership of Australian Joint Ventures
Cooks Coffee Company Trading Update
September 30th Morning Report